Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project

Abstract

Despite recent advances in the management of CIRD, incidence of CVD remains increased in Spanish subjects with CIRD attending outpatient rheumatology clinics.

Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study

“…Currently the data regarding associations with diabetes is contradictory with some studies suggesting diabetes is common for both PsA [23,24] and Ps patients [25], whilst other data, including our own, showed no association [18]. This may be related to variation in the study designs and the populations used.…”

“…Castañeda et al also examined hypertension in both AS and PsA patients from the Spanish population and though found prevalence rates of 26% & 30% respectively, after multivariate analysis only PsA was significant (p = <0.05) compared to controls [18]. A cross-sectional secondary care sample from Belgium also found the prevalence of hypertension (32.8%) to be significantly greater in PsA patients than those with related, but non-PsA forms of spondyloarthritis [19].…”

Cardiovascular risk factor assessment: still an unmet need in chronic inflammatory diseases

“…Recent data fully support previous studies that highlighted an increased frequency of traditional CV risk factors in patients with chronic inflammatory diseases 2 4. Besides adequate treatment of the inflammatory disease, there is a growing concern among some clinicians about the need of adequate CV disease risk stratification to reduce the risk of CV events in patients with chronic inflammatory diseases 5…”

Consensus Statement on the Management of Comorbidity in Patients with Rheumatoid Arthritis and Psoriasis

“…First, despite substantial gaps in the current knowledge and management of cardiovascular (CV) risk in patients with chronic inflammatory rheumatic diseases (CIRD; recommendation 1), a recent work demonstrates that the prevalence of CV disease remains high even in subjects with CIRD periodically evaluated at rheumatology clinics 4 . This applies to almost half of the patients receiving biological therapy, even though most of them have low disease activity 4 .…”

“…This applies to almost half of the patients receiving biological therapy, even though most of them have low disease activity 4 . …”